The Narcotics Substances Ordinance defines cannabis (hemp) - including its extracts, tinctures and other preparations made from it - as flower or fruit heads of plants belonging to the cannabis genus, from which the resin has not been extracted. Cannabis and cannabis resin are considered narcotic substances. No imminent changes to the regulatory framework for hemp and medicinal cannabis are expected in Austria, though depending on the results of the next elections, there could be amendments in the future.
This report offers a detailed summary of the current regulatory framework in place for CBD, hemp and cannabis in Austria. It covers everything from hemp cultivation and processing, to finished products and extracts, and the country's medical and recreational cannabis policies.
Table of Contents
1 Executive Summary
2 Outlook
3 Hemp Plant
4 Extracts And Synthetic as Finished Products
5 Finished Products Containing CBD and Extracts
6 Import And Export Requirements
7 Medical Cannabis
8 Recreational Cannabis
9 Relevant Laws
10 Relevant Bodies
Methodology
General Methodology/Sources
- Consumer and market participant (manufacturer/brand) surveys.
- Consolidation of publicly available information.
- Legal tracking through legal database checking and sourcing information from government regulators and other law-making bodies.
- Pricing and product information from online and offline retail data gathering, including local fieldwork teams.
- Findings from key industry events and interviews with leading market players and opinion leaders.
- Partnerships with leading research agencies.
- Quantitative and qualitative research and client collaborations.
- Cross-referenced data between markets.
- Tamarind Media proprietary market model.
Please note that each report has its own methodology, so you should always refer to the methodology applied in the report you purchase.
LOADING...
